With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation, and a 62-year dividend growth streak. CL demonstrates resilience amid inflation, with robust margins, ...

Fears of a recession make investors actively reposition their portfolios, and defensive companies such as Colgate-Palmolive have non-cyclical characteristics. The company outperforms its peers in ...

Colgate-Palmolive Company CL continues to be a favorite among investors, thanks to its strategy of strengthening leadership in key product categories through core business innovation, exploring growth ...

Colgate-Palmolive Company CL is in a good spot, thanks to its robust business strategies. Strong pricing and funding-the-growth and other productivity initiatives have been bolstering the company’s ...